CD276 and graft versus host disease: Finally, we showed in a highly sensitive human allo-GVHD model in vivo that in HLA-mismatched transplantation, CD45RA/CD276-depleted CD4+ grafts delay the onset of GVHD and attenuate the severity compared with sole CD45RA-depleted CD4+ grafts.